What happened
SK biopharmaceuticals disclosed a supply contract with SK Life Science,Inc., worth US$55.8M, about 11.5% of its recent annual revenue, running through Jul 2026.
For context, this single contract equals about 11.5% of the company's most recent annual revenue.
| Counterparty | SK Life Science,Inc. |
|---|---|
| Contract value | US$55.8M |
| vs. recent revenue | 11.5% |
| Through | Jul 2026 (from Jul 2026) |
| Filed | 2026-07-28, Supply contract signed |
| Source | DART rcept 20260728800426 → open original filing |
Source: DART. Information only, not investment advice.